A newly identified mutation dramatically raises prostate cancer risk in Ashkenazi Jewish men and may increase sensitivity to ...

Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk o ...

A diabetes drug may hold the key to preventing prostate cancer relapse. Scientists discovered that prostate cancer patients ...

Experts explain the science behind Biden's advanced prostate cancer diagnosis, including how common it is and what treatments are available.

The UCSF study also promotes eating fruits and vegetables to lower the risk of prostate cancer because of the vitamins, ...

Urologist Dr. Jamin Brahmbhatt knows the complexities surrounding prostate-specific antigen testing with his patients. Here’s ...

Prostate cancer (PCa) remains a leading cause of cancer-related mortality globally, with late-stage diagnoses contributing to ...